Brimonidine Tartrate Solution/ Drops
Product Images NDC 42571-419

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 42571-419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimonidine-carta.jpg (Brimonidine Carta)

Brimonidine-carta.jpg (Brimonidine Carta)
Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.2%, 5 mL, sterile drops for topical ophthalmic use. Label includes the NDC 42571-419-92 and states Rx only. Manufactured by Micro Labs Limited, with manufacturing location in Bangalore, India, and distributed by Micro Labs USA, Inc. The label features a warning not to touch the dropper tip to any surface and a caution about the integrity of the tear-off ring. Ingredients and storage instructions are also provided.*
FDA Label Image

Brimonidine-lbla.jpg (Brimonidine Lbla)

Brimonidine-lbla.jpg (Brimonidine Lbla)
Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, a sterile eye drop solution with a 5 mL volume. The label includes dosage and storage instructions, indicates prescription use only, and displays the Micro Labs logo. Manufactured for Micro Labs USA, Inc., Somerset, NJ, and made in India.*
FDA Label Image

Brimonidine-str.jpg (Brimonidine Str)

Brimonidine-str.jpg (Brimonidine Str)
Chemical structure of brimonidine tartrate showing the molecular arrangement of the active ingredient's atoms and bonds in the ophthalmic solution form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.